Pharmacie Hankar SRL
3.0 FTEPharmacie Hankar reported total assets of 205,159 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026), with 3 full-time equivalents.
The score of Pharmacie Hankar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets -33 % Headcount (avg FTE) -3 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Hankar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
Pharmacie Hankar's financial analysis
- Solvency-64.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Hankar
Pharmacie Hankar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.489.377
- VAT number
- BE0795489377
- Peppol
- Registered · 0208:0795489377 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2022
- Registered office
- 1160 Auderghem
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Hankar (SRL) has been based in Auderghem since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 52,669 € and equity of −132,780 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Hankar
Companies in the same business, of comparable size and area, outside its group.
- Vivapharma Retail sale of pharmaceutical products Auderghem · balance sheet 236,296 €
- Hacklo Retail sale of pharmaceutical products Hasselt · balance sheet 159,726 €
- PTMS Consultancy Retail sale of pharmaceutical products Londerzeel · balance sheet 192,606 €
- Luc Thaens Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 204,672 €
- Walpharma Retail sale of pharmaceutical products Arlon · balance sheet 202,753 €
- Sivahe Retail sale of pharmaceutical products Hasselt · balance sheet 172,297 €
- Apotheek van Dionant Retail sale of pharmaceutical products Beersel · balance sheet 229,148 €
- Melbuj Retail sale of pharmaceutical products Wemmel · balance sheet 237,909 €
Frequently asked questions about Pharmacie Hankar
What is the revenue of Pharmacie Hankar?
Pharmacie Hankar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Hankar?
In Belgium, the VAT number is the company number prefixed with BE: BE0795489377 for Pharmacie Hankar, if the company is VAT-registered. Its company number (CBE) is 0795.489.377.
Where is the registered office of Pharmacie Hankar?
According to the CBE register, the registered office of Pharmacie Hankar is in 1160 Auderghem.
What is the equity of Pharmacie Hankar?
At the close of the 2025 financial year, the equity of Pharmacie Hankar amounts to -132,780 €, a solvency of -64.7% of total assets.
How many people work at Pharmacie Hankar?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmacie Hankar?
The register lists 2 active mandates at Pharmacie Hankar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Hankar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →